| Literature DB >> 32784722 |
Vanessa Silva1,2,3,4, Cecília Peirone5,6,7, Joana S Amaral8,9, Rosa Capita10,11, Carlos Alonso-Calleja10,11, José A Marques-Magallanes12, Ângela Martins13, Águeda Carvalho6, Luís Maltez5,14, José Eduardo Pereira5,14, José Luís Capelo15,16, Gilberto Igrejas2,3,4, Patrícia Poeta1,4.
Abstract
Ozone has a high wound healing capacity and antibacterial properties and can be used as a complementary treatment in infections. Methicillin-resistant S. aureus (MRSA) is the most common pathogen found in infected diabetic foot ulcers. Most of MRSA are resistant to several classes of antibiotics and, therefore, there is a need for new, effective, and well-tolerated agents. Thus, we aimed evaluate the antimicrobial and antibiofilm potentials of ozonated vegetable oils against MRSA strains isolated from diabetic foot ulcers. Six ozonated oils were produced with concentrations of ozone ranging from 0.53 to 17 mg of ozone/g of oil. The peroxide values were determined for each oil. Ozonated oils content on fatty acid was determined by gas chromatography equipped with a flame ionization detector. The antimicrobial susceptibility testing was performed by the Kirby-Bauer disk diffusion method and the effect of ozonated oils on biofilm formation ability and on established biofilms was investigated. In general, the content in identified unsaturated fatty acid in oils decreased with the increase of ozonation time and, consequently, the peroxide value increased. Most bacterial strains were inhibited by ozonated oil at a concentration of 4.24 mg/g. Ozonated oils had moderate to high ability to remove adhered cells and showed a high capacity to eradicate 24 h old biofilms. Our results show promising use of ozonated oils on the treatment of infections, in particular those caused by multidrug-resistant MRSA strains.Entities:
Keywords: MRSA; S. aureus; biofilms; diabetic foot ulcers; ozonated oil; ozone
Mesh:
Substances:
Year: 2020 PMID: 32784722 PMCID: PMC7464232 DOI: 10.3390/molecules25163601
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Effect of ozone treatment on peroxide values. Values are presented as mean ± standard deviation (n = 2). CTR—control.
| Sample | Ozonation time | Peroxide Value 1 |
|---|---|---|
| CTR | 0 | 3.9 ± 0.0 a |
| 1 | 10 min | 44.4 ± 3.4 b |
| 2 | 20 min | 69.5 ± 4.6 c |
| 3 | 40 min | 83.4 ± 5.3 c |
| 4 | 80 min | 101.7 ± 4.7 d |
| 5 | 160 min | 113.5 ± 3.7 d |
| 6 | 320 min | 220.7 ± 5.6 e |
1 Peroxide value was expressed as milli-equivalents (meq) peroxide per 1 kg oil. Analysis of variance (ANOVA) was performed, with different letters (a–e) indicating significant differences (p < 0.05).
Percentage composition of fatty acids in oils control sample (CTR) and ozonated samples. Values are presented as mean ± standard deviation (n = 2).
| Fatty acid | Sample CTR | Sample 1 | Sample 2 | Sample 3 | Sample 4 | Sample 5 | Sample 6 |
|---|---|---|---|---|---|---|---|
|
| 0.05 ± 0.00 a | 0.04 ± 0.00 a | 0.05 ± 0.00 a | 0.05 ± 0.00 a | 0.06 ± 0.00 a | 0.06 ± 0.00 a | 0.33 ± 0.02 b |
|
| 8.45 ± 0.25 a | 8.65 ± 0.11 a | 8.91 ± 0.08 a | 9.23 ± 0.08 a,b | 9.94 ± 0.05 b | 11.53 ± 0.18 c | 14.67 ± 0.53 d |
|
| 0.41 ±0.00 a | 0.42 ± 0.00 a | 0.40 ± 0.03 a | 0.06 ± 0.03 b,c | 0.06 ± 0.00 b,c | 0.04 ± 0.00 b | 0.12 ± 0.03 c |
|
| 0.24 ±0,00 a | 0.24 ± 0.00 a | 0.41 ± 0.00 a,b | 0.78 ± 0.05 b | 1.57 ± 0.02 c | 2.72 ± 0.07 d | 6.58 ± 0.37 e |
|
| 0.06 ±0.00 a | 0.06 ± 0.00 a | 0.06 ± 0.00 a | 0.05 ± 0.00 a | 0.03 ± 0.03 a | 0.05 ± 0.01 a | 0.65 ± 0.03 b |
|
| 3.24 ± 0.14 a | 3.21 ± 0.00 a | 3.41 ± 0.01 a | 3.82 ± 0.08 a | 4.68 ± 0.02 b | 6.52 ± 0.17 c | 8.58 ± 0.40 d |
|
| 53.19 ± 0.68 a | 52.11 ± 0.68 a,b | 51.02 ± 0.07 b,c | 50.19 ± 0.38 c,d | 46.56 ± 0.16 e | 40.07 ± 0.51 f | 17.50 ± 0.60 g |
|
| 2.29 ± 0.00 a | 2.18 ± 0.04 a,b | 2.16 ± 0.01 a,b | 2.07 ± 0.09 b,c | 1.98 ± 0.02 c | 1.76 ± 0.04 d | 0.49 ± 0.02 e |
|
| 30.70 ± 1.13 a | 29.72 ± 0.39 a | 28.89 ± 0.05 a,b | 27.35 ± 0.42 b | 23.24 ± 0.13 c | 17.05 ± 0.48 d | 5.87 ± 0.28 e |
|
| 0.17 ± 0.02 a | 0.16 ± 0.01 a | 0.18 ± 0.01 a | 0.16 ± 0.02 a | 0.15 ± 0.01 a,b | 0.10 ± 0.02 b | n.d. |
|
| 0.31 ± 0.01 a | 0.31 ± 0.02 a | 0.31 ± 0.00 a | 0.30 ± 0.03 a | 0.34 ± 0.07 a | 0.42 ± 0.03 a | 0.39 ± 0.02 a |
|
| 0.27 ± 0.01 a | 0.27 ± 0.01 a | 0.27 ± 0.00 a | 0.24 ± 0.03 a,b | 0.19 ± 0.02 b,c | 0.12 ± 0.02 c | 0.14 ± 0.03 c |
|
| 0.50 ± 0.05 a | 0.47 ± 0.08 a | 0.60 ± 0.01 a,b | 0.84 ± 0.08 b | 1.27 ± 0.01 c | 1.93 ± 0.09 d | 2.29 ± 0.13 e |
|
| 0.13 ± 0.00 a | 0.12 ± 0.00 a | 0.13 ± 0.02 a | 0.13 ± 0.03 a | 0.21 ± 0.06 a | 0.39 ± 0.07 b | 0.51 ± 0.01 b |
|
|
|
|
|
|
|
|
|
n.d.: not determined; total ID: % of identified compounds. ANOVA analysis was performed, with different letters (a–g) indicating significant differences (p < 0.05). CTR: control (non ozonated oil); samples 1, 2, 3, 4, 5, and 6 correspond to 10, 20, 40, 80, 160, and 320 min of ozone treatment, respectively.
Figure 1Minimum inhibitory concentrations (MIC) of ozonated oils against 28 methicillin-resistant S. aureus (MRSA) (black) and 10 methicillin-susceptible S. aureus (MSSA) (grey) strains.
Figure 2Percentage of biomass removal of ozonated oils at MIC value on (a) adhered cells and (b) 24 h old biofilms of 28 MRSA (black) and 10 MSSA (grey) strains.